Protecting Cancer Patients from COVID-19
As we see the start of a year long roll out of the COVID-19 vaccination, an innovative clinical trial is focused on strengthening the immune system for one of the...
Read More
January 4, 2021 / News
November 8, 2020 / News
New Normal Same Cancer
Oncologists worldwide are concerned about the disruptions COVID-19 has caused to cancer treatments. When the world stopped, cancer didn’t. Don’t wait. Get checked!
Read More
November 6, 2020 / News
Protect Our Access
The federal government has proposed new regulations that threaten your access to life-saving medicines. These changes mean fewer life-changing medicines available to us. It will force Canadians to leave the...
Read More
November 5, 2020 / News
COVID-19 & CancerCantWait
The COVID-19 crisis has heightened anxieties and concerns among patients and caregivers about receiving adequate cancer care. It has also led to postponed appointments, procedures and treatments which have clearly...
Read More
November 4, 2020 / News
Competition Bureau Launches Survey About Digital Health Services in Canada
The Competition Bureau of Canada wants to better understand the barriers Canadians may face in accessing and using health services through digital technology. But to do that, they need your...
Read More
November 3, 2020 / News
Radon Risk: Test Your Home Today to Find Out if You Have a Dangerous Level
Radon exposure is the leading cause of lung cancer among non-smokers in Canada. Raising public awareness is a critical first step toward protecting Canadians from the health risks associated with...
Read More
October 15, 2020 / News
CCSN Congratulates Stewart Campbell, for Being the Recipient of the Pathfinder Award.
The Canadian Cancer Survivor Net would like to congratulate Stewart Campbell, Chairman of ProstAid Calgary for being the recipient of the 2020 Pathfinder Award. The Pathfinder Award is given to...
Read More
October 13, 2020 / News
Lynparza® (olaparib) Receives Health Canada Approval for the Treatment of BRCA or ATM Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Lynparza is the first targeted treatment approved in biomarker-selected prostate cancer validated by a Phase III trial Read the full press release provided by AstraZeneca Canada Inc.
Read More
September 7, 2020 / News
Anxieties of cancer patients and caregivers about phone and virtual appointments during the pandemic
Before COVID-19, seeing a doctor or specialist generally meant seeing them in person. Now, it typically means talking to them on the phone, or perhaps over a video call. Although...
Read More
September 2, 2020 / News
Cancer still waiting…
If you think that COVID-19 disruption of cancer care is nearly over, think again! CCSN’s recent Leger survey of 1,243 Canadians revealed that the response to the COVID-19 pandemic has...
Read More